[Opportunistic infections in HIV-infected subjects: no wonders].
Ermak
T N
TN
Peregudova
A V
AV
Gruzdev
B M
BM
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000209:etiology; D000328:Adult; D000962:Antimalarials / Q000627:therapeutic use*; D004338:Drug Combinations; D042241:Early Diagnosis; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D016781:Toxoplasmosis, Cerebral / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine